Ionis Pharmaceuticals IONS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$92.53M+59.7% | -$229.39M-78.4% | -$128.61M-204% | $123.55M+184% | -$146.94M-40.8% | ||
| $3.3M+1.3% | $3.26M+44.5% | $2.26M-0.5% | $2.27M+1.7% | $2.23M-0.5% | ||
| $43.28M-0.1% | $43.32M+39.1% | $31.15M+4.9% | $29.69M-0.1% | $29.72M-17.8% | ||
| $218K+171% | -$308K-245% | $213K+1,165% | -$20K-117% | $116K-96.7% | ||
| $2.35M+19.4% | $1.97M+19.1% | $1.65M+0.4% | $1.65M+0.2% | $1.64M-1.9% | ||
| -$338K— | $0-100% | $2.14M-84.2% | $13.48M+1,434% | -$1.01M-120% | ||
| -$3.1M— | —— | -$8.81M— | —— | -$25.97M-174% | ||
| $7.39M— | —— | $100.95M+893% | $10.17M-17.8% | $12.37M-30.1% | ||
| $21M— | —— | $84.15M+2,528% | $3.2M+862% | $333K+102% | ||
| $7.63M-88.7% | $67.58M+342% | -$27.97M-317% | $12.87M+125% | -$52.48M— | ||
| -$20.82M-8.8% | -$19.13M-18.7% | -$16.11M+22.4% | -$20.77M-51.4% | -$13.72M+4.1% | ||
| $161K-93.8% | $2.61M+12,960% | $20K— | $0-100% | $92K+1,414% | ||
| $40K-99.1% | $4.63M+217% | -$3.94M-1,769% | $236K+287% | $61K-97.0% | ||
| $22.58M+2,766% | $788K-97.4% | $29.91M+263% | -$18.31M-746% | -$2.16M+15.7% | ||
| $3.49M+1.2% | $3.44M+112% | $1.63M-37.2% | $2.59M+0.1% | $2.59M+0.7% | ||
| -$792.82M-476% | -$137.71M-4.8% | -$131.44M-187% | $151.34M+200% | -$150.78M-29.8% | ||
| $21.76M+2.2% | $21.29M+304% | $5.27M-57.2% | $12.31M-2.2% | $12.58M-50.7% | ||
| $192.76M-75.7% | $791.97M+144% | $323.94M-34.1% | $491.59M+58.0% | $311.07M-6.8% | ||
| $752.82M+90.5% | $395.12M-6.4% | $422.21M+9.4% | $385.79M-22.0% | $494.76M+15.1% | ||
| $1.49M+8.9% | $1.37M-17.8% | $1.66M-15.5% | $1.96M+202% | $651K-74.4% | ||
| —— | —— | $19.6M— | —— | —— | ||
| —— | $228.9M0.0% | $228.9M0.0% | $228.9M0.0% | $228.9M+1.6% | ||
| $536.82M+228% | -$419.51M-559% | $91.34M+176% | -$120.07M-170% | $170.46M— | ||
| $57.3M— | $0+100% | -$3.53M-374% | $1.29M-42.6% | $2.24M+8,200% | ||
| $57.26M-90.3% | $591.18M+628% | $81.22M+6,413% | $1.25M-43.3% | $2.2M— | ||
| -$138K— | —— | —— | $595K+156% | $232K+148% | ||
| -$198.88M-686% | $33.92M-17.3% | $41.04M+23.9% | $33.11M+49.7% | $22.12M+124% | ||
| $90K-98.3% | $5.38M+2,810% | $185K-96.4% | $5.12M+5,467% | $92K-98.2% | ||
| -$8K— | —— | -$278K— | —— | -$400K+94.8% | ||
| $6.19M+9.1% | $5.67M+11.5% | $5.09M-13.4% | $5.87M-17.4% | $7.11M-24.8% | ||
| $43.28M-0.1% | $43.32M+39.1% | $31.15M+4.9% | $29.69M-0.1% | $29.72M-17.8% | ||
| $2.35M+19.4% | $1.97M+19.1% | $1.65M+0.4% | $1.65M+0.2% | $1.64M-1.9% | ||
| $661K+3.6% | $638K+2.7% | $621K+3.8% | $598K+2.7% | $582K+26.8% | ||
| $3.3M+1.3% | $3.26M+44.5% | $2.26M-0.5% | $2.27M+1.7% | $2.23M-0.5% | ||
| $22.58M+2,766% | $788K-97.4% | $29.91M+263% | -$18.31M-746% | -$2.16M+15.7% | ||
| —— | —— | —— | —— | —— | ||
| $7.63M— | —— | -$27.97M— | —— | -$52.48M— | ||
| —— | $669.75K0.0% | $669.75K0.0% | $669.75K0.0% | $669.75K+227% | ||
| $21M— | —— | $84.15M+2,528% | $3.2M+862% | $333K+102% | ||
| -$80.19M-235% | $59.22M— | —— | —— | -$43.04M-248% | ||
| $7.39M— | —— | $100.95M+893% | $10.17M-17.8% | $12.37M-30.1% | ||
| —— | $4.09M0.0% | $4.09M0.0% | $4.09M0.0% | $4.09M— | ||
| $3.49M+1.2% | $3.44M+112% | $1.63M-37.2% | $2.59M+0.1% | $2.59M+0.7% | ||
| $22.58M— | $0-100% | $29.91M+261% | -$18.62M-907% | -$1.85M+28.1% | ||
| $1.49M+8.9% | $1.37M-17.8% | $1.66M-15.5% | $1.96M+202% | $651K-74.4% | ||
| $752.82M+90.5% | $395.12M-6.4% | $422.21M+9.4% | $385.79M-22.0% | $494.76M+15.1% | ||
| —— | —— | $19.6M— | —— | —— | ||
| $57.3M-46.9% | $107.82M+32.7% | $81.26M+6,214% | $1.29M-42.6% | $2.24M+457% | ||
| $44K-15.4% | $52K+26.8% | $41K+2.5% | $40K-4.8% | $42K+2.4% | ||
| —— | $19.6M0.0% | $19.6M0.0% | $19.6M0.0% | $19.6M-52.8% | ||
| $2.98M-62.5% | $7.96M+240% | $2.34M-43.7% | $4.15M+184% | $1.46M-61.8% | ||
| $363.52M-13.0% | $417.79M+31.8% | $316.9M+1.5% | $312.23M+12.1% | $278.47M-17.5% | ||
| —— | $446.5K0.0% | $446.5K0.0% | $446.5K0.0% | $446.5K+129% | ||
| —— | $645K0.0% | $645K0.0% | $645K0.0% | $645K+404% | ||
| —— | $2.65M0.0% | $2.65M0.0% | $2.65M0.0% | $2.65M+23.3% | ||
| —— | 21%— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | -5.1%— | —— | —— | —— | ||
| —— | -0.1%— | —— | —— | —— | ||
| —— | -4.7%— | —— | —— | —— | ||
| —— | -$95.3M0.0% | -$95.3M0.0% | -$95.3M0.0% | -$95.3M+17.3% | ||
| —— | $394.75K0.0% | $394.75K0.0% | $394.75K0.0% | $394.75K+145% | ||
| —— | —— | —— | —— | —— | ||
| $5.16M+6.9% | $4.83M+14.6% | $4.21M+2.4% | $4.11M+0.1% | $4.11M-2.0% | ||
| 1+300% | 0.30.0% | 0.30.0% | 0.30.0% | 0.3— | ||
| -$138K— | $0+100% | -$82K-114% | $595K+156% | $232K+148% | ||
| —— | $203.33M— | —— | —— | —— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $1.79M0.0% | $1.79M0.0% | $1.79M0.0% | $1.79M+96.2% | ||
| —— | $34.25K0.0% | $34.25K0.0% | $34.25K0.0% | $34.25K-98.2% | ||
| —— | $11.5K0.0% | $11.5K0.0% | $11.5K0.0% | $11.5K— | ||
| —— | -$162K0.0% | -$162K0.0% | -$162K0.0% | -$162K— | ||
| -$8K— | —— | -$278K— | —— | -$400K+94.8% | ||
| -$814.58M-412% | -$159M-16.3% | -$136.71M— | —— | -$163.35M-15.3% | ||
| -$814.58M-412% | -$159M-16.3% | -$136.71M— | —— | -$163.35M-15.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ionis Pharmaceuticals generate?
- Ionis Pharmaceuticals (IONS) generated -$910.6M in operating cash flow over the trailing twelve months.
- What is Ionis Pharmaceuticals's free cash flow?
- After $60.6M of capital expenditures, Ionis Pharmaceuticals's free cash flow was -$1.3B over the trailing twelve months, down 133.2% year over year.
- Where does Ionis Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ionis Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
